The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins
Central nervous system responses to cannabis are primarily mediated by CB(1) receptors, which couple preferentially to G(i/o) G proteins. Here, we used calcium photometry to monitor the effect of CB(1) activation on intracellular calcium concentration. Perfusion with 5 microM CB(1) aminoalkylindole...
Saved in:
| Published in: | Proceedings of the National Academy of Sciences - PNAS Vol. 102; no. 52; p. 19144 |
|---|---|
| Main Authors: | , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
United States
27.12.2005
|
| Subjects: | |
| ISSN: | 0027-8424 |
| Online Access: | Get more information |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | Central nervous system responses to cannabis are primarily mediated by CB(1) receptors, which couple preferentially to G(i/o) G proteins. Here, we used calcium photometry to monitor the effect of CB(1) activation on intracellular calcium concentration. Perfusion with 5 microM CB(1) aminoalkylindole agonist, WIN55,212-2 (WIN), increased intracellular calcium by several hundred nanomolar in human embryonic kidney 293 cells stably expressing CB(1) and in cultured hippocampal neurons. The increase was blocked by coincubation with the CB(1) antagonist, SR141716A, and was absent in nontransfected human embryonic kidney 293 cells. The calcium rise was WIN-specific, being essentially absent in cells treated with other classes of cannabinoid agonists, including Delta(9)-tetrahydrocannabinol, HU-210, CP55,940, 2-arachidonoylglycerol, methanandamide, and cannabidiol. The increase in calcium elicited by WIN was independent of G(i/o), because it was present in pertussis toxin-treated cells. Indeed, pertussis toxin pretreatment enhanced the potency and efficacy of WIN to increase intracellular calcium. The calcium increases appeared to be mediated by G(q) G proteins and phospholipase C, because they were markedly attenuated in cells expressing dominant-negative G(q) or treated with the phospholipase C inhibitors U73122 and ET-18-OCH(3) and were accompanied by an increase in inositol phosphates. The calcium increase was blocked by the sarco/endoplasmic reticulum Ca(2+) pump inhibitor thapsigargin, the inositol trisphosphate receptor inhibitor xestospongin D, and the ryanodine receptor inhibitors dantrolene and 1,1'-diheptyl-4,4'-bipyridinium dibromide, but not by removal of extracellular calcium, showing that WIN releases calcium from intracellular stores. In summary, these results suggest that WIN stabilizes CB(1) receptors in a conformation that enables G(q) signaling, thus shifting the G protein specificity of the receptor. |
|---|---|
| AbstractList | Central nervous system responses to cannabis are primarily mediated by CB(1) receptors, which couple preferentially to G(i/o) G proteins. Here, we used calcium photometry to monitor the effect of CB(1) activation on intracellular calcium concentration. Perfusion with 5 microM CB(1) aminoalkylindole agonist, WIN55,212-2 (WIN), increased intracellular calcium by several hundred nanomolar in human embryonic kidney 293 cells stably expressing CB(1) and in cultured hippocampal neurons. The increase was blocked by coincubation with the CB(1) antagonist, SR141716A, and was absent in nontransfected human embryonic kidney 293 cells. The calcium rise was WIN-specific, being essentially absent in cells treated with other classes of cannabinoid agonists, including Delta(9)-tetrahydrocannabinol, HU-210, CP55,940, 2-arachidonoylglycerol, methanandamide, and cannabidiol. The increase in calcium elicited by WIN was independent of G(i/o), because it was present in pertussis toxin-treated cells. Indeed, pertussis toxin pretreatment enhanced the potency and efficacy of WIN to increase intracellular calcium. The calcium increases appeared to be mediated by G(q) G proteins and phospholipase C, because they were markedly attenuated in cells expressing dominant-negative G(q) or treated with the phospholipase C inhibitors U73122 and ET-18-OCH(3) and were accompanied by an increase in inositol phosphates. The calcium increase was blocked by the sarco/endoplasmic reticulum Ca(2+) pump inhibitor thapsigargin, the inositol trisphosphate receptor inhibitor xestospongin D, and the ryanodine receptor inhibitors dantrolene and 1,1'-diheptyl-4,4'-bipyridinium dibromide, but not by removal of extracellular calcium, showing that WIN releases calcium from intracellular stores. In summary, these results suggest that WIN stabilizes CB(1) receptors in a conformation that enables G(q) signaling, thus shifting the G protein specificity of the receptor.Central nervous system responses to cannabis are primarily mediated by CB(1) receptors, which couple preferentially to G(i/o) G proteins. Here, we used calcium photometry to monitor the effect of CB(1) activation on intracellular calcium concentration. Perfusion with 5 microM CB(1) aminoalkylindole agonist, WIN55,212-2 (WIN), increased intracellular calcium by several hundred nanomolar in human embryonic kidney 293 cells stably expressing CB(1) and in cultured hippocampal neurons. The increase was blocked by coincubation with the CB(1) antagonist, SR141716A, and was absent in nontransfected human embryonic kidney 293 cells. The calcium rise was WIN-specific, being essentially absent in cells treated with other classes of cannabinoid agonists, including Delta(9)-tetrahydrocannabinol, HU-210, CP55,940, 2-arachidonoylglycerol, methanandamide, and cannabidiol. The increase in calcium elicited by WIN was independent of G(i/o), because it was present in pertussis toxin-treated cells. Indeed, pertussis toxin pretreatment enhanced the potency and efficacy of WIN to increase intracellular calcium. The calcium increases appeared to be mediated by G(q) G proteins and phospholipase C, because they were markedly attenuated in cells expressing dominant-negative G(q) or treated with the phospholipase C inhibitors U73122 and ET-18-OCH(3) and were accompanied by an increase in inositol phosphates. The calcium increase was blocked by the sarco/endoplasmic reticulum Ca(2+) pump inhibitor thapsigargin, the inositol trisphosphate receptor inhibitor xestospongin D, and the ryanodine receptor inhibitors dantrolene and 1,1'-diheptyl-4,4'-bipyridinium dibromide, but not by removal of extracellular calcium, showing that WIN releases calcium from intracellular stores. In summary, these results suggest that WIN stabilizes CB(1) receptors in a conformation that enables G(q) signaling, thus shifting the G protein specificity of the receptor. Central nervous system responses to cannabis are primarily mediated by CB(1) receptors, which couple preferentially to G(i/o) G proteins. Here, we used calcium photometry to monitor the effect of CB(1) activation on intracellular calcium concentration. Perfusion with 5 microM CB(1) aminoalkylindole agonist, WIN55,212-2 (WIN), increased intracellular calcium by several hundred nanomolar in human embryonic kidney 293 cells stably expressing CB(1) and in cultured hippocampal neurons. The increase was blocked by coincubation with the CB(1) antagonist, SR141716A, and was absent in nontransfected human embryonic kidney 293 cells. The calcium rise was WIN-specific, being essentially absent in cells treated with other classes of cannabinoid agonists, including Delta(9)-tetrahydrocannabinol, HU-210, CP55,940, 2-arachidonoylglycerol, methanandamide, and cannabidiol. The increase in calcium elicited by WIN was independent of G(i/o), because it was present in pertussis toxin-treated cells. Indeed, pertussis toxin pretreatment enhanced the potency and efficacy of WIN to increase intracellular calcium. The calcium increases appeared to be mediated by G(q) G proteins and phospholipase C, because they were markedly attenuated in cells expressing dominant-negative G(q) or treated with the phospholipase C inhibitors U73122 and ET-18-OCH(3) and were accompanied by an increase in inositol phosphates. The calcium increase was blocked by the sarco/endoplasmic reticulum Ca(2+) pump inhibitor thapsigargin, the inositol trisphosphate receptor inhibitor xestospongin D, and the ryanodine receptor inhibitors dantrolene and 1,1'-diheptyl-4,4'-bipyridinium dibromide, but not by removal of extracellular calcium, showing that WIN releases calcium from intracellular stores. In summary, these results suggest that WIN stabilizes CB(1) receptors in a conformation that enables G(q) signaling, thus shifting the G protein specificity of the receptor. |
| Author | Hille, Bertil Mackie, Ken Lauckner, Jane E |
| Author_xml | – sequence: 1 givenname: Jane E surname: Lauckner fullname: Lauckner, Jane E organization: Department of Physiology and Biophysics, Neurobiology and Behavior Graduate Program, University of Washington, Seattle, WA 98195, USA – sequence: 2 givenname: Bertil surname: Hille fullname: Hille, Bertil – sequence: 3 givenname: Ken surname: Mackie fullname: Mackie, Ken |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/16365309$$D View this record in MEDLINE/PubMed |
| BookMark | eNo1kL1PwzAQxT0U0Q-Y2ZAnJtL6I3bsESoolSpYihiji-MUo8RO4wSJ_55UlOlO-r179_TmaOKDtwjdULKkJOOr1kNcEkG0UIoSNkEzQliWqJSlUzSP8YuQEyOXaEoll4ITPUPH_afFBryHwvngSgyH4F3s8cf2VYh7RlnCsPOmsxBtHLe-A2PreqihG-9q44YGfzvA60eKO2ts24cRhKGtnT_gPuDNcUUp3uC2C711Pl6hiwrqaK_Pc4Hen5_265dk97bZrh92Scuk6BMFVFNSZQXPSpMZpqwqOKSUKSIZN4xXQmqp01KaTFPQ2qRMAzDFQUkqgC3Q3Z_v-Pg42NjnjYun6OBtGGIuNUmFSPUovD0Lh6KxZd52roHuJ_8vif0C9q5nhA |
| ContentType | Journal Article |
| DBID | CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1073/pnas.0509588102 |
| DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | no_fulltext_linktorsrc |
| Discipline | Sciences (General) |
| ExternalDocumentID | 16365309 |
| Genre | Journal Article Research Support, N.I.H., Extramural |
| GrantInformation_xml | – fundername: NIAMS NIH HHS grantid: R01 AR017803 – fundername: NIDA NIH HHS grantid: K02 DA000286 – fundername: NIDA NIH HHS grantid: R01 DA011322 – fundername: NIDA NIH HHS grantid: DA09150 – fundername: NINDS NIH HHS grantid: R01 NS008174 – fundername: NIDA NIH HHS grantid: DA11322 – fundername: NINDS NIH HHS grantid: NS08174 – fundername: NIDA NIH HHS grantid: R01 DA014486 – fundername: NINDS NIH HHS grantid: R37 NS008174 – fundername: NIAMS NIH HHS grantid: AR17803 |
| GroupedDBID | --- -DZ -~X .55 .GJ 0R~ 123 29P 2AX 2FS 2WC 3O- 4.4 53G 5RE 5VS 85S AACGO AAFWJ AANCE AAYJJ ABBHK ABOCM ABPLY ABPPZ ABTLG ABXSQ ABZEH ACGOD ACHIC ACIWK ACNCT ACPRK ADQXQ ADULT AENEX AEUPB AEXZC AFFNX AFOSN AFRAH ALMA_UNASSIGNED_HOLDINGS AQVQM AS~ BKOMP CGR CS3 CUY CVF D0L DCCCD DIK DU5 E3Z EBS ECM EIF EJD F5P FRP GX1 H13 HH5 HQ3 HTVGU HYE IPSME JAAYA JBMMH JENOY JHFFW JKQEH JLS JLXEF JPM JSG JST KQ8 L7B LU7 MVM N9A NEJ NPM N~3 O9- OK1 P-O PNE PQQKQ R.V RHI RNA RNS RPM RXW SA0 SJN TAE TN5 UKR VOH W8F WH7 WHG WOQ WOW X7M XSW Y6R YBH YKV YSK ZCA ZCG ~02 ~KM 7X8 ADXHL |
| ID | FETCH-LOGICAL-p265t-8a1910f7b37dc7c28e8b3a41280623c23f569694d6c791a99c429aa283a8615a2 |
| IEDL.DBID | 7X8 |
| ISSN | 0027-8424 |
| IngestDate | Fri Sep 05 13:33:38 EDT 2025 Thu Apr 03 07:00:33 EDT 2025 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 52 |
| Language | English |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-p265t-8a1910f7b37dc7c28e8b3a41280623c23f569694d6c791a99c429aa283a8615a2 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 16365309 |
| PQID | 69045549 |
| PQPubID | 23479 |
| ParticipantIDs | proquest_miscellaneous_69045549 pubmed_primary_16365309 |
| PublicationCentury | 2000 |
| PublicationDate | 2005-12-27 |
| PublicationDateYYYYMMDD | 2005-12-27 |
| PublicationDate_xml | – month: 12 year: 2005 text: 2005-12-27 day: 27 |
| PublicationDecade | 2000 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Proceedings of the National Academy of Sciences - PNAS |
| PublicationTitleAlternate | Proc Natl Acad Sci U S A |
| PublicationYear | 2005 |
| SSID | ssj0009580 |
| Score | 2.3569844 |
| Snippet | Central nervous system responses to cannabis are primarily mediated by CB(1) receptors, which couple preferentially to G(i/o) G proteins. Here, we used calcium... |
| SourceID | proquest pubmed |
| SourceType | Aggregation Database Index Database |
| StartPage | 19144 |
| SubjectTerms | Analgesics - pharmacology Animals Arachidonic Acids - chemistry Benzoxazines Calcium - chemistry Calcium - metabolism Cannabinoids - chemistry Cell Line Cyclohexanols - pharmacology Cytoplasm - metabolism DNA, Complementary - metabolism Dronabinol - analogs & derivatives Dronabinol - pharmacology Endocannabinoids Endoplasmic Reticulum - metabolism Excitatory Amino Acid Antagonists - pharmacology Fluorescent Dyes - pharmacology Fura-2 - analogs & derivatives Fura-2 - pharmacology Glycerides - chemistry GTP-Binding Protein alpha Subunits, Gq-G11 - chemistry GTP-Binding Protein alpha Subunits, Gq-G11 - physiology Hippocampus - metabolism Humans Immunosuppressive Agents - pharmacology Morpholines - pharmacology Naphthalenes - pharmacology Neurons - metabolism Pertussis Toxin - pharmacology Piperidines - pharmacology Protein Binding Protein Conformation Pyrazoles - pharmacology Rats Receptor, Cannabinoid, CB1 - chemistry Receptor, Cannabinoid, CB1 - metabolism Rimonabant Ryanodine - pharmacology Time Factors Type C Phospholipases - metabolism |
| Title | The cannabinoid agonist WIN55,212-2 increases intracellular calcium via CB1 receptor coupling to Gq/11 G proteins |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/16365309 https://www.proquest.com/docview/69045549 |
| Volume | 102 |
| hasFullText | |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1LT9wwELZo6aEXyrYUKI_6wKGVajaxndiWkBAgdtsDEYdW3dtqcGwUCZJss7u_n3EeEhfUA5fcJnIm45lvxp5vCDlxPpRrhGDCx45JaVIGIDwDIZUzqeKRhXbYhMoyPZuZ2w1yNvTChGuVg09sHXVe2VAjH2MWJzH0mfN6wcLMqHC22g_QeEM2BQKZYNNqpp9R7uquAYWjH5ZcDsQ-SozrEprTwHySaB23FZUX0GUbZSYfXre-bbLVo0t60ZnDiGy48iMZ9fu3od96kunvn8gC7YOiWkvA1Lgqcgr3VSDRpX9_ZUnyA0MN47QoA6ZsULIINeBQ5A-3VlHuwRarR7ougF5dxhS9pqsxeae2WoUO33u6rOh0MY5jOqUtE0RRNjvkz-T699VP1o9fYDVPkyXTgLlc5NWdULlVlmun7wTIOJzFcmG58ElqUiPz1CoTgzEWYxsA4hXQiJOAfyZvy6p0e4QmaAkiyZ31TkphI-NTr5y2PM814Lv3yddBqXM07_A5ULpq1cwHte6T3e6_zOuOhWOOQDJNRGS-_Ff2gLzvCFdDI9Ih2fS4sd0ReWfXy6L5d9xaDT6z25snAtzLQg |
| linkProvider | ProQuest |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+cannabinoid+agonist+WIN55%2C212-2+increases+intracellular+calcium+via+CB1+receptor+coupling+to+Gq%2F11+G+proteins&rft.jtitle=Proceedings+of+the+National+Academy+of+Sciences+-+PNAS&rft.au=Lauckner%2C+Jane+E&rft.au=Hille%2C+Bertil&rft.au=Mackie%2C+Ken&rft.date=2005-12-27&rft.issn=0027-8424&rft.volume=102&rft.issue=52&rft.spage=19144&rft_id=info:doi/10.1073%2Fpnas.0509588102&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0027-8424&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0027-8424&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0027-8424&client=summon |